Journal Logo

Poster Session I: Acute myeloid leukemia - Biology & translational research

PF201 THE COMBINATION OF IMGN632, A CD123-TARGETING ADC, WITH VENETOCLAX ENHANCES ANTI-LEUKEMIC ACTIVITY IN VITRO AND PROLONGS SURVIVAL IN VIVO IN PRE-CLINICAL MODELS OF HUMAN AML

Adams, S.1; Zhang, Q.2; McCarthy, R.1; Flaherty, L.J.1; Watkins, K.1; Sloss, C.M.1; Romanelli, A.1; Zweidler-McKay, P.1; Konopleva, M.2

Author Information
doi: 10.1097/01.HS9.0000559020.72361.fa
  • Free

Abstract

Copyright © 2019 the Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the European Hematology Association.